Pharmaceuticals - Community Register

  

Community list of not active medicinal products for human use


WITHDRAWN  

Product information

Invented name: Indimacis 125
Auth. number : EU/1/96/025
INN : Igovomab
ATC: Anatomical main group: V - Various
Therapeutic subgroup: V09 - Diagnostic radiopharmaceuticals
Pharmacological subgroup: V09I - Tumour detection
Chemical subgroup: V09IB - Indium (111In) compounds
Chemical substance: V09IB03 - Indium (111In) antiovariumcarcinoma antibody
(See WHO ATC Index)
Indication: Diagnosis of ovarian adenocarcinoma
Marketing Authorisation Holder: CIS bio international
route Nationale 306, Saclay, Boite Postale 32, F-91192 Gif-sur-Yvette, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/10/1996 Centralised - Authorisation EMEA/H/C/65 (96)2725 of 04/10/1996
02/10/1997 Centralised - Variation EMEA/H/C/65/N/2 (97)2949 of 01/10/1997
30/09/1999 Centralised - Withdrawal (1999)2962 of 14/09/1999